Literature DB >> 22922827

miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma.

Cheng-Kui Cai1, Guang-Yi Zhao, Li-Ying Tian, Lie Liu, Kang Yan, Yun-Lei Ma, Zhen-Wei Ji, Xiao-Xiang Li, Kang Han, Jie Gao, Xiu-Chun Qiu, Qing-Yu Fan, Tong-Tao Yang, Bao-An Ma.   

Abstract

Osteosarcoma, the most common primary tumor of the bones, causes many deaths due to its rapid proliferation and drug resistance. Recent studies have shown that cyclin D1 plays a key regulatory role during cell proliferation, and non-coding microRNAs (miRNAs) act as crucial modulators of cyclin D1 (CCND1). The aim of the current study was to determine the role of miRNAs in controlling CCND1 expression and inducing cell apoptosis. CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA. The upregulation of miR-15a and miR-16-1 in the cell line SOSP-9607 induces apoptosis and cell cycle arrest. Osteosarcoma cells transfected with miR-15a and miR-16-1 show slower proliferation curves. Moreover, the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region (3'-UTR). The data presented here demonstrate that the CCND1 contributes to osteosarcoma cell proliferation, suggesting that repression of CCND1 by miR-15a and miR-16-1 could be used for osteosarcoma therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922827     DOI: 10.3892/or.2012.1995

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  71 in total

1.  TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.

Authors:  Zaijun Lin; Dianwen Song; Haifeng Wei; Xinghai Yang; Tielong Liu; Wangjun Yan; Jianru Xiao
Journal:  J Cancer Res Clin Oncol       Date:  2015-08-15       Impact factor: 4.553

2.  MicroRNA-128 promotes proliferation in osteosarcoma cells by downregulating PTEN.

Authors:  Lei Shen; Xiao-Dong Chen; Yao-Hui Zhang
Journal:  Tumour Biol       Date:  2013-10-15

Review 3.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

4.  MiR-16-1 Targeted Silences Far Upstream Element Binding Protein 1 to Advance the Chemosensitivity to Adriamycin in Gastric Cancer.

Authors:  Danyi Zhao; Yang Zhang; Lei Song
Journal:  Pathol Oncol Res       Date:  2017-06-30       Impact factor: 3.201

5.  The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.

Authors:  Ritu Shekhar; Priyanka Priyanka; Praveen Kumar; Tanushree Ghosh; Md Muntaz Khan; Perumal Nagarajan; Sandeep Saxena
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

Review 6.  The validity of circulating microRNAs in oncology: five years of challenges and contradictions.

Authors:  J Jarry; D Schadendorf; C Greenwood; A Spatz; L C van Kempen
Journal:  Mol Oncol       Date:  2014-03-06       Impact factor: 6.603

7.  MicroRNA library-based functional screening identified miR-137 as a suppresser of gastric cancer cell proliferation.

Authors:  Xiushan Zheng; Jiaqiang Dong; Taiqian Gong; Zhiyong Zhang; Ying Wang; Yunming Li; Yulong Shang; Kai Li; Gui Ren; Bin Feng; Juntang Li; Qifei Tian; Shanhong Tang; Li Sun; Mengbin Li; Hongwei Zhang; Daiming Fan
Journal:  J Cancer Res Clin Oncol       Date:  2014-10-24       Impact factor: 4.553

8.  miR-132 targeting cyclin E1 suppresses cell proliferation in osteosarcoma cells.

Authors:  Jin Wang; Guoxing Xu; Feng Shen; Yifan Kang
Journal:  Tumour Biol       Date:  2014-01-22

9.  Analysis of the molecular mechanism of osteosarcoma using a bioinformatics approach.

Authors:  Jianxun Yang; Ning Wang
Journal:  Oncol Lett       Date:  2016-08-29       Impact factor: 2.967

10.  miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy.

Authors:  Qingping Jiang; Yajie Zhang; Mengyang Zhao; Qiulian Li; Ruichao Chen; Xiaobing Long; Weiyi Fang; Zhen Liu
Journal:  Tumour Biol       Date:  2015-09-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.